Table 1.

Characteristics of included patients with adverse drug reactions

Characteristics (N=294)N (%)
Gender (female)202 (69%)
Age (years) (mean ± SD)53 ± 13
Smoking59 (20%)
BMI (kg/m2) (mean ± SD)25.7 ± 5.3
Reported ARDs (mean ± SD)1.4 ± 0.8
Indication
Rheumatoid arthritis129 (44%)
Psoriatic arthritis51 (17%)
Axial spondyloarthritis43 (15%)
Crohn’s disease42 (14%)
Other indications29 (10%)
Biologic
Adalimumab97 (33%)
Etanercept72 (24%)
Infliximab27 (9%)
Tocilizumab16 (5%)
Secukinumab15 (5%)
Rituximab14 (5%)
Other biologics53 (18%)